Skip to main content

This translation is provided for general access and has no recorded medical-language review.

Editorial general information — not a clinical-review record

Published: Updated: Publisher: Dr. Murat Toktamışoğlu

Why are allergy and anaphylaxis preparedness reviewed beforehand?

Products, antiseptics, latex, adhesives or anaesthetics can cause different reactions; details of a previous event change risk planning. General information must be interpreted with personal history, examination, current product or device documentation, local regulation and follow-up capacity.

This translation has no recorded clinical or medical-language review.

Direct answer

  • Products, antiseptics, latex, adhesives or anaesthetics can cause different reactions; details of a previous event change risk planning.
  • General information must be interpreted with personal history, examination, current product or device documentation, local regulation and follow-up capacity.
  • Share trigger, symptoms, timing and treatment and ask about emergency medicines, trained staff, equipment and ambulance activation.

Assessment framework

Products, antiseptics, latex, adhesives or anaesthetics can cause different reactions; details of a previous event change risk planning. General information must be interpreted with personal history, examination, current product or device documentation, local regulation and follow-up capacity. This information is not a diagnosis, prescription, personal suitability decision or fixed procedure plan.

Questions for consultation

Share trigger, symptoms, timing and treatment and ask about emergency medicines, trained staff, equipment and ambulance activation. Alternatives, the option of no procedure, material risks, follow-up and urgent warning signs should also be discussed individually.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

  1. Dermal Fillers (Soft Tissue Fillers)

    U.S. Food and Drug Administration (FDA) · 2023

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  2. Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion

    Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  3. Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review

    Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  4. International Consensus Guidelines on the Safe and Evidence-Based Practice of Mesotherapy: A Multidisciplinary Statement

    Massimo Mammucari, Domenico Russo, Enrica Maggiori, Marco Rossi, Marzia Lugli, Raffaele Di Marzo, Alberto Migliore, Raimondo Leone, Kamil Koszela, Giustino Varrassi; International Expert Panel · 2025

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  5. Efficacy and Safety of Amino Acid-Enriched Hyaluronic Acid in Facial Rejuvenation: A Systematic Review and Meta-Analysis

    Maite Mosteirin, Ava Guila Ardila, Raul Gil Calomarde, Gonzalo Mariscal · 2026

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  6. Injectable Therapy for Androgenetic Alopecia: A Systematic Review

    Jacob Beer, Tanya Boghosian, Hannah Mendez, Mira Sayegh, Nazar Boghosian, Antonella Tosti · 2026

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review